http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3439733-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc73f70d0171afe91d13519d6f4906c5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40
filingDate 2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a9bee2976a6e099cce8ab48938ab2b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3066ea251887683129c17fed72b0d2c
publicationDate 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3439733-A1
titleOfInvention Reducing motility of cancer cells using tumor treating fields (ttfields)
abstract The spreading of cancer cells in a target region can be inhibited by imposing a first AC electric field in the target region for a first interval of time, with a frequency and amplitude selected to disrupt mitosis of the cancer cells; and imposing a second AC electric field in the target region for a second interval of time, with a frequency and the amplitude selected to reduce motility of the cancer cells. The amplitude of the second AC electric field is lower than the amplitude of the first AC electric field.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-202100000119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022149061-A1
priorityDate 2016-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2471

Total number of triples: 23.